Tourmaline Bio, Inc.

Symbol
TRML on Nasdaq
Entity
Company
Business address
27 West 24 Th Street, Suite 702, 10010 New York, NY
Phone
646-481-9832
State of incorporation
DE
Fiscal year end
December 31
Category
Non-accelerated filer
Smaller reporting company
Emerging growth company
Former names
Talaris Therapeutics, Inc. (to 10/18/2023)
All SEC filings
View on sec.gov
Get insider transactions for this issuer
Tourmaline Bio, Inc. has filed 287 SEC EDGAR filings since 10/7/2020

Latest Filings